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Abstract-Physiology in microgravity is a challenging field of research because of limited resources.
Though humans have been in space for 50 years most meaningful data has been collected only
within the last 15 years. While expensive studies with small sample sizes make obtaining and
interpreting data difficult, some general conclusions about the human physiological response to
microgravity can be drawn. A redistribution of bodily fluids is believed to initiate change in
cardiovascular and respiratory function. The mechanisms for these changes have been studied
very little are not well understood. Long term effects of microgravity on the body have been
impossible to study in the past. Larger studies must be done for increased time periods in order to
better characterize the underlying physiological mechanisms involved in the body’s response to
microgravity.
I. INTRODUCTION
Physiological studies in microgravity are
relatively young. Mostly all knowledge in the
area has been collected over only the last 50
years. The first living animal to be sent into
space was the Soviet dog Laika in November
1957, and the first human to enter space was Yuri
Gagarin on April 12, 1961 [10]. Studies that
were done early on were not very sophisticated
and many times the control conditions were
insufficient to render meaningful data. The most
valuable studies of physiology in space were done
in Spacelabs in the 90s. Spacelab was a reusable
laboratory carried into orbit by the space shuttle
that was designed to allow scientists to do
experimentation in microgravity under controlled
conditions. In June 1991, a Spacelab devoted to
life sciences was launched into orbit where major
experiments involving cardiovascular and
pulmonary function and other physiological
responses were performed [10]. This mission
produced much of the knowledge of human
physiology in microgravity that is known today.
Physiological systems of animals have adapted to
the earth’s gravitational field over their entire
existence.
These adaptations are more
pronounced in terrestrial species with great
height. For example, the cardiovascular system
in giraffes, ostriches, and tree climbing snakes
have sophisticated mechanisms that provide
blood flow to the brain and restrict pooling of
blood and swelling in tissues of the lower

extremities. Because humans spend much time in
the upright position, they have also developed
mechanisms to regulate blood flow throughout
the body.
When considering that these
mechanisms are designed to compensate for
gravity, it seems logical that physiology will be
affected by prolonged weightlessness.
The cardiovascular system is significantly
agitated by loss of gravity. It has long been
thought that a headward shift in bodily fluids is
experienced when gravity is eliminated.
“Because humans are predominantly upright
creatures, with the majority of the blood located
below heart level, gravity has a profound effect
on the mechanical distribution of fluid within the
cardiovascular system.
When hydrostatic
gradients are removed, such as changing from the
upright to the supine position or exposure to
microgravity, blood is translocated from the
lower part of the body towards the chest virtually
doubling the amount of blood within the heart
[6].” This shift in fluid distribution is considered
to produce a transient increase in central blood
volume. The heart responds to the increase in
volume and increases the stroke volume
according to the Frank-Starling mechanism. The
increase in stoke volume is detected by stretch
receptors in the heart and interpreted as an
increase in total blood volume. This triggers
what is known as the Gauer-Henry reflex [11].
Atrial distension results and increased headward
blood pressures reduce vasopressin secretion and
sympathetic nervous activity [5]. The reduced

sympathetic outflow depresses the reninangiotensin-aldosterone process [5]. The atrial
distension also increases secretion of atrial
natriuretic peptide [5].
The Gauer-Henry
response is thought to increase urine production
and reduce blood volume [5].
Pulmonary physiology in space is sometimes
neglected because weightlessness has not caused
adverse affects on the lungs of the astronauts. In
contrast, microgravity obviously deteriorates
other systems of the body including the
cardiovascular system, muscles, and bones [5].
While it is a first priority in space research to
study problems in physiology that would inhibit
sustained living and production in space, the lung
turns out to be very sensitive to gravity. Loss of
gravity can cause marked changes in the
distribution of blood flow in the lungs,
ventilation, gas exchange, alveolar size,
intrapleural pressures, and mechanical stresses in
the lungs [5].
Many factors make physiology in space a
challenging research topic. Sometimes data is not
collected under rigorous laboratory conditions,
but rather in uncontrolled field conditions.
Prelaunch posture, psychological excitement,
stress, medical problems associated with
microgravity, environmental fluctuations in
spacecraft, and other hurdles make data collection
and interpretation difficult [5]. Another obstacle
is the small sample sizes available which prevent
adequate statistical comparisons [5]. Despite the
difficulty in obtaining data, there are still
conclusions that can be made about physiology in
space.

tissues and interstitial fluid; and (5) an
intravascular hydrostatic pressure due to gravity
or gravitational pressure [5]. The intravascular
hydrostatic pressure is the component that
changes in zero gravity. This pressure is defined
at a certain point in the vasculature as the product
of the density of blood (~1.06 g/ml), the
magnitude of acceleration, and the distance of the
point of interest above or below the hydrostatic
indifference level (HIL) [5]. The HIL is the place
in the circulation where hydrostatic pressure
remains constant with acute changes in
orientation of an organism with respect to the
gravity vector [5]. The loss of gravity eliminates
hydrostatic blood pressure gradients throughout
the vasculature. The normal location for the HIL
in humans is just below the diaphragm. The
location of the HIL depends on the relative
compliance of the vessels throughout the body. If
the vessels in the lower body become more
compliant, the HIL shifts to a lower point in the
body. This shift causes changes in cardiac
function due to differences in the cardiac filling
pressure.
Arterial pressures around the level of the heart
remain relatively unchanged in microgravity, but
hypothetically
the
peripheral
circulation
experiences increased transmural pressures in the
upper body and decreased pressures in the lower
body. Figure 1 shows an expected change in
distribution of tissue fluid and arterial pressures
experienced during spaceflight. The darker areas
represent more tissue fluid.
The numbers
represent arterial pressures in units of mmHg.

II. BACKGROUND
1) Cardiac Response: Blood pressure are
determined by five components on earth: (1) the
dynamic pressure resulting from cardiac pumping
against peripheral resistance to blood flow; (2)
dynamic pressures due to inertial forces of blood
during activity; (3) pressure due to the finite
compliance of the systemic vasculature,
especially the veins; (4) extravascular pressure of
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Figure 1: Hypothetical distribution of tissue fluid and
arterial pressures experienced with spaceflight [5]

While the heart will be affected immediately by
changes in filling pressures, it is reasonable that
long term exposure to microgravity could alter the
structure and function of the heart.
In order to understand the long term effects of
microgravity on the cardiovascular system, it is
important to recognize the immediate response
which most likely initiates long term effects. The
sudden loss of circulatory gravitational pressures
could lead to central blood redistribution and
transvascular fluid movements [5].
A study was done in 1987 in attempt to measure
fluid redistribution [8]. These studies validate the
movement of fluid away from the legs in
microgravity. Figure 2 is leg fluid volume loss
data collected from 3 astronauts over a 7 day
mission. MD refers to the mission day.

Figure 2: Leg fluid volume reduction during spaceflight
[8]

The leg fluid volume decreased 7.7% or ~.6 liters
in each leg by 1 hour after insertion into orbit [8].
In 1991, seven subjects were studied over a nine
day mission to observe acute affects in cardiac
output [9]. Figure 3 is a plot of stroke volume
expressed as a percentage of preflight standing
stroke volume.

Figure 3: Stroke volume as a percentage of preflight
standing stroke volume [9]

2) Respiratory Response: In comparison to other
organs of the body, the lung occupies a large
volume compared to its mass. The lung is
designed to be less dense to provide air space for
gas exchange to the blood. The compliant
structure of the lung causes it to deform under its
own weight. On earth, gravity causes regional
differences in lung bloodflow, ventilation, gas
exchange, alveolar size, intrapleural pressure, and
mechanical stress [5]. It is reasonable to think
that these regional differences will be reduced or
eliminated in microgravity.
Experiments were done under parabolic flight
conditions in attempt to evaluate blood
distribution in the lungs at 0g, 1g, and 2g [7].
Subjects hyperventilated in order to reduce PCO2
in all regions of the lung. The subjects then held
their breath for 15 seconds and PO2 and PCO2
was measured with a mass spectrometer during
subsequent vital capacity expiration. The idea
was that PO2 and PCO2 would change in opposite
directions at a rate determined by bloodflow per
unit volume in any region of the lungs.
Cardiogenic oscillations are caused by
preferential emptying of certain regions of the
lung more than other regions [7]. Therefore, the
size of cardiogenic oscillations during exhalation
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would be a measure of the topographical
inequality of the bloodflow throughout the lungs.
Figure 4 shows the PO2 and PCO2 during 0g, 1g,
and 2g. The insets are cardiogenic oscillations
amplified from the signals.

Similar studies were done to evaluate reduced
inequality in ventilation in microgravity [7].
Inequality of ventilation was measured from
single-breath nitrogen washouts performed with
an initial bolus of argon at residual volume.
Figure 6 are measurements using mass
spectrometry of the nitrogen washouts done at 1g
(top) and 0g (bottom).

Figure 4: Effect of short periods of 0g, 1g, and 2g on the
inhomogeneity of pulmonary bloodflow as measured by
cardiogenic oscillations [7]

The cardiogenic oscillations were exaggerated
during increased acceleration and were almost
eliminated during 0g. This is evidence for
reduced topographical inequality of bloodflow in
microgravity [7].
Figure 5 shows a plot of the magnitude of the
cardiogenic oscillations as a function of
acceleration.
Figure 6: Single breath nitrogen washouts showing the
effect of microgravity on ventilation [7]

Larger cardiogenic oscillations were seen at 1g
indicating preferential emptying of the lungs [7].
There is also a terminal rise in the signal at 1g.
This rise is a result of the upper region of the lung
near the end of the expiration associated with
airway closure, or failure of the basal region to
empty for some other reason [7].
III. RESEARCH QUESTIONS

Figure 5: Cardiogenic oscillations as a function of
gravity during PO2 and PCO2 measurements [7]

1) Central venous pressure: It is understood that
gravity affects cardiac filling pressure and
intravascular fluid distribution. Data collected
validating increases in cardiac output due to loss
of gravity, would imply that cardiac filling
pressure must also increase. However, this is not
the case. In order to understand the dynamics of
these parameters it was necessary to measure the
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central venous pressure (CVP) which is the
pressure at the right atrium of the heart.
Using catheters and pressure transducers the CVP
was directly measured on 3 subjects aboard the
Spacelab Life Sciences space shuttle flights [1].
Data collected provided a continuous CVP signal
with pressures changes from earth to orbit.
Figure 7 is the CVP data for 1 of the subjects.

2) Long term exposure to microgravity: Perhaps
one of the most difficult challenges facing space
researchers is to understand physiological effects
due to long term exposure to microgravity. A
mission to Mars would take on the order of 1,000
days, which is three times longer than anybody
has ever been in space so far [10]. Much
physiologic data collected has been done during
parabolic flight which allows for only 20-30s of
weightlessness [5]. While initial physiologic
responses may been seen, the rapid changes in
acceleration do not allow for long term study.
The international space station is supposed to
offer better opportunities to do long term studies.
This project consists of components from the
U.S., Russia, Europe, Japan, Canada, and other
countries. Astronauts should be able to reside for
extended periods to do more elaborate studies.
Even with the space station, studies are very
expensive and many times are delayed by many
complications.

Figure 7: Central venous pressure at prelaunch, launch,
and orbit

As expected, CVP increases during launch which
is probably a result of anteroposterior
compression of the thorax and abdomen caused
by acceleration forces up to 3g [1]. Once in
space, however, CVP dropped rapidly below
preflight levels contradictory to expected
increases with fluid volume redistribution [1].
These results pose interesting questions about the
result of fluid redistribution in the body due to
microgravity. The mechanisms that cause a
simultaneous decrease in CVP and increase in
cardiac output are not understood. The results
indicating this illogical behavior in the
cardiovascular system suggest that the effects of
the fluid redistribution are more complex than
initially thought.
Results from the CVP study are limited in that
only three subjects were measured.

Medical devices that can perform easy, noninvasive measurements will be increasingly
useful in advancing knowledge of space
physiology. At this stage there is very little
information about the effects of microgravity on
physiology. Many questions will remain a
mystery without better opportunities to test larger
numbers of subjects for larger amounts of time.
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